Prof Belinda Lennox - The future of drug treatment for schizophrenia

Exploring Advances in Psychopharmacology with Professor Belinda Lennox. Conference insights from BAP2024.

Join André from the Mental Elf as he interviews Professor Belinda Lennox from the University of Oxford at the BAP 2024 conference in Birmingham.

They discuss the significance of the British Association for Psychopharmacology (BAP) as a key meeting for British psychopharmacologists, highlighting its vibrant community and interdisciplinary focus.

Professor Lennox delves into the historical and recent advancements in psychosis treatment, the emerging hope from new pharmacological compounds, and the importance of repurposing drugs for psychiatric use.

Discover insights into current research trends, such as the 'psychedelic renaissance' and innovative clinical trial designs derived from oncology research.

00:00 Introduction and Greetings
00:12 The Significance of BAP Conference
01:32 Interdisciplinary Collaboration in Psychopharmacology
02:01 Current State and Future of Psychosis Treatment
03:05 The Psychedelic Renaissance
04:11 Exciting New Developments in Psychosis Treatment
06:15 Repurposing Drugs for Mental Health
06:29 Innovative Clinical Trials in Psychosis
08:21 Conclusion and Final Thoughts